Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Superior Outcome of Bone Marrow Transplantation Using Fludarabine and Cyclophosphamide with ATG over Fludarabine and Cyclophosphamide without ATG Conditioning Regimen in Severe Aplastic Anemia

Blood (2023) 142 (Supplement 1): 6951.

https://doi.org/10.1182/blood-2023-182333

Published: 2023

Journal Articles

Allogeneic Stem Cell Transplantation in Adolescent and Adult Patients with Acute T Cell Lymphoblastic Leukemia / Lymphoma : Single Center Experience of 143 Patients

Blood (2023) 142 (Supplement 1): 7101.

https://doi.org/10.1182/blood-2023-185676

Published: 2023

Journal Articles

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing

Blood (2023) 142 (Supplement 1): 7433.

https://doi.org/10.1182/blood-2023-187940

Published: 2023

Journal Articles

Patterns of Graft-Versus-Host Disease (GvHD) Prevention and Management in the Eastern Mediterranean (EM) Region: A Worldwide Network for Blood & Marrow Transplantation (WBMT) Survey

Blood (2023) 142 (Supplement 1): 7029.

https://doi.org/10.1182/blood-2023-182995

Published: 2023

Journal Articles

Utility and Validity of Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Predicting Overall Survival and Non-Relapse Mortality in Adolescent and Young Adult Population

Blood (2022) 140 (Supplement 1): 10566–10567.

https://doi.org/10.1182/blood-2022-167509

Published: 2022

Journal Articles

Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients : A Single Center Analysis of 97 Patients

Blood (2022) 140 (Supplement 1): 11471–11473.

https://doi.org/10.1182/blood-2022-162734

Published: 2022

Journal Articles

Allogeneic Hematopoietic Cell Transplant Yields Long Term Disease Free Survival in a Significant Number of Patients with Classic Hodgkin Lymphoma

Blood (2022) 140 (Supplement 1): 12969–12970.

https://doi.org/10.1182/blood-2022-164820

Published: 2022

Journal Articles

Sequential Fludarabine, Ara-C, Etoposide (FLAV) Followed By Fludarabine/ Busulfan Reduced Toxicity Conditioning Is Safe and Effective Salvage for Adult Patients with Refractory Acute Myeloid Leukemia and High Risk Myelodysplasia

Blood (2021) 138 (Supplement 1): 1851.

https://doi.org/10.1182/blood-2021-152602

Published: 2021

Journal Articles

A Clinical, Genomic and Proteomic Approach for the Characterization of Fanconi Anemia in Adolescent and Young Adult (AYA) Patients : A Single Center Study of 55 Patients from a National Bone Marrow Failure Referral Center

Blood (2018) 132 (Supplement 1): 2594.

https://doi.org/10.1182/blood-2018-99-114639

Published: 2018

Journal Articles

The Impact of Early Post-Transplant Cyclosporine Induced Acute Nephrotoxicity on Long Term Renal Function in 2-Year Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Retrospective Study

Reem Alharbi, Mahmoud Aljurf, MD, Raid El Fakih, MD, Mohammad Al Nahedh, PharmD, Majed Huessein, MD, Zubeir Ahmed Nurgat, BSc, MSc, Almohareb Fahad, MD, Naeem A. Chaudhri, MD, Fahad Z. Alsharif, MB, MD, Hazza A. Alzahrani, MD, Walid Rasheed, MB, ChB, FRACP, FRCPA, Amr Suleiman Hanbali, MD, Marwan Shaheen, MD, Feras Al Fraih, MD, Saud Alhayli, MD, Riad Youniss, Shahrukh Hashmi, MD, Syed Osman Ahmed, BSc, FRCPath, MBBS, MRCP

Blood (2018) 132 (Supplement 1): 3358.

https://doi.org/10.1182/blood-2018-99-114667

Published: 2018

Journal Articles

Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients

Ayodele Alaiya, MPH, MBBS, PhD, Mahmoud Aljurf, MD, Zakia Shinwari, MSc, Fahad Z. Alsharif, MB, MD, Hazza A. Alzahrani, MD, Syed Osman Ahmed, BSc, FRCPath, MBBS, MRCP, Tarek Owaidah, MD FRCPA, Amr Suleiman Hanbali, MD, Marwan Shaheen, MD, Feras Al Fraih, MD, Riad Elfakih, MD, Saud Alhayli, MD, Shahrukh Hashmi, MD, Walid Rasheed, MB, ChB, FRACP, FRCPA, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD

Blood (2018) 132 (Supplement 1): 5434.

https://doi.org/10.1182/blood-2018-99-118754

Published: 2018

Journal Articles

Development of Unique Molecular Signatures for Bone Marrow Failure Syndromes

Ayodele Alaiya, MBBS,MPH,PhDFRCPath, Zakia Shinwari, MSc, Hazza Alzahrani, MD, Tarek Owaidah, MD, Fahad Al Mohareb, MD, Fahad Z. Alsharif, MB,MD, Randa M Alnounou, MD, Walid Rasheed, MB, CHB, FRACP, FRCPA, Raid El Fakih, MD, Amr Hanbali, MD, Marwan Shaheen, MD, Feras Abdulaziz Alfraih, MD, Hashmi Shahrukh, MD, Majed Dasouki, MD, Naeem A. Chaudhri, MD, Syed Osman Ali Ahmed, BSc, FRCPath, MBBS, MRCP, Mahmoud Aljurf

Blood (2017) 130 (Supplement 1): 2465.

https://doi.org/10.1182/blood.V130.Suppl_1.2465.2465

Published: 2017

Journal Articles

Impact of Anti-Hepatitis B Core Following Allogeneic Bone Marrow Transplantation; Single Center Study of 489 Patients

Muhned Alhumaid, MD, Syed Osman Ali Ahmed, BSc, FRCPath, MBBS, MRCP, Fahad Al Mohareb, MD, Fahad Z. Alsharif, MB,MD, Hazzaa Alzahrani, MD, Naeem A. Chaudhri, MD, Raid El Fakih, MD, Amr Hanbali, MD, Shahrukh K. Hashmi, MDMPH, Said Yousuf Ahmed, MD, Walid Rasheed, MB, CHB, FRACP, FRCPA, Marwan Shaheen, MD, Tusneem Elhassan, MSc, Feras Abdulaziz Alfraih, MD

Blood (2017) 130 (Supplement 1): 5498.

https://doi.org/10.1182/blood.V130.Suppl_1.5498.5498

Published: 2017

Journal Articles

Addition of ATG to Myeloablative Haplo Conditioning with Post-Transplantation Cyclophosphamide Might Decrease the Risk of Gvhd and TRM without Increasing the Risk of Relapse

Blood (2016) 128 (22): 5871.

https://doi.org/10.1182/blood.V128.22.5871.5871

Published: 2016

Journal Articles

BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation; Incidence and Risk Factors

Feras Alfraih, MD, Amjad Alhussaini, Farhan Anjum, Ghuzayel Mubarak Aldawsari, Fahad Alsharif, MD, Said Y Mohamed, MD, Walid Rasheed, MD, Syed Osman Ahmed, MRCP, FRCPath, Amr Hanbali, MD, Marwan Shaheen, MD, Riad O. El Fakih, MD, Hazza A Alzahrani, MD, Naeem A. Chaudhri, MD FACP, Fahad Almohareb, Mahmoud Aljurf, MD MPH

Blood (2016) 128 (22): 5759.

https://doi.org/10.1182/blood.V128.22.5759.5759

Published: 2016

Journal Articles

Real-World Data Indicates That the Addition of Etoposide to Idarubicin and Cytarabine (3+7) Induction in Young Adults (<60 years) with AML Does Not Improve Survival or Remission Rates

Blood (2016) 128 (22): 4010.

https://doi.org/10.1182/blood.V128.22.4010.4010

Published: 2016

Journal Articles

Influence of Matched Sibling Donor's Availability and Stem Cell Transplantation on Treatment Outcome for Acute Lymphoblastic Leukemia; Study on 294 Patients

Feras Alfraih, MD, Wahiba Chebbo, Dennis Dong Hwan Kim, MD PhD, Ghuzayel Aldawsari, MD, Fahad Z. Alsharif, MBChB, MD, Hazza A Alzahrani, MD, Said Y Mohamed, MD, Walid Rasheed, MD, Amr Hanbali, MD, Syed Osman Ahmed, MRCP, FRCPath, Marwan Shaheen, MD, Naeem A. Chaudhri, MD FACP, Fahad Al Mohareb, MD, Mahmoud Aljurf, MD MPH

Blood (2015) 126 (23): 4387.

https://doi.org/10.1182/blood.V126.23.4387.4387

Published: 2015

Journal Articles

Young Adult Patients with Post -HCT Relapse of AML May Benefit from Aggressive Salvage and 2 nd Cellular Therapy

Syed Osman Ahmed, MRCP, FRCPath, Amna Gamil, MD, Muhamad Hitham Almahayni, MD MRCP,, Naeem A. Chaudhri, MD FACP, Fahad Alsharif, MD, Said Y Mohamad, MD, Hazza A Alzahrani, MD, Walid Rasheed, MD, Ghuzayel Aldawsari, MD, Amr Hanbali, MD, Marwan Shaheen, MD, Feras Alfraih, MD, Shad Ahmed, MD, Khaled Ibrahim, Fahed Almhareb, MD, Mahmoud Aljurf, MD MPH

Blood (2015) 126 (23): 5482.

https://doi.org/10.1182/blood.V126.23.5482.5482

Published: 2015

Journal Articles

CD20 Expression Is Associated with Higher Risk of Early Relapse at 1 Year Following Chemotherapy Treatment for Adolescent and Adult Acute Lymphoblastic Leukemia Patients

Feras Alfraih, MD, Abdul Mannnan, Dennis Dong Hwan Kim, MD PhD, Ghuzayel Aldawsari, MD, Fahad Z. Alsharif, MBChB, MD, Hazza A Alzahrani, MD, Said Y Mohamed, MD, Walid Rasheed, MD, Amr Hanbali, MD, Syed Osman Ahmed, MRCP, FRCPath, Marwan Shaheen, MD, Fahad Al Mohareb, MD, Mahmoud Aljurf, MD MPH, Naeem A. Chaudhri, MD FACP

Blood (2015) 126 (23): 3728.

https://doi.org/10.1182/blood.V126.23.3728.3728

Published: 2015

Journal Articles

Fertility Recovery Following Allogeneic Bone Marrow Transplantation in Aplastic Anemia; A Study of 157 Patients

Feras Alfraih, MD, Shad Ahmed, MD, Dennis Dong Hwan Kim, MD PhD, Walid Rasheed, MD, Ghuzayel Aldawsari, MD, Fahad Alsharif, MD, Said Y Mohamed, MD, Amr Hanbali, MD, Syed Osman Ahmed, MRCP, FRCPath, Marwan Shaheen, MD, Naeem A. Chaudhri, MD FACP, Fahad Al Mohareb, MD, Mahmoud Al-Jurf, MD, Hazza A Alzahrani, MD

Blood (2015) 126 (23): 4783.

https://doi.org/10.1182/blood.V126.23.4783.4783

Published: 2015

NARROW

Superior Outcome of Bone Marrow Transplantation Using Fludarabine and Cyclophosphamide with ATG over Fludarabine and Cyclophosphamide without ATG Conditioning Regimen in Severe Aplastic Anemia

Allogeneic Stem Cell Transplantation in Adolescent and Adult Patients with Acute T Cell Lymphoblastic Leukemia / Lymphoma : Single Center Experience of 143 Patients

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing

Patterns of Graft-Versus-Host Disease (GvHD) Prevention and Management in the Eastern Mediterranean (EM) Region: A Worldwide Network for Blood & Marrow Transplantation (WBMT) Survey

Utility and Validity of Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Predicting Overall Survival and Non-Relapse Mortality in Adolescent and Young Adult Population

Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients : A Single Center Analysis of 97 Patients

Allogeneic Hematopoietic Cell Transplant Yields Long Term Disease Free Survival in a Significant Number of Patients with Classic Hodgkin Lymphoma

Sequential Fludarabine, Ara-C, Etoposide (FLAV) Followed By Fludarabine/ Busulfan Reduced Toxicity Conditioning Is Safe and Effective Salvage for Adult Patients with Refractory Acute Myeloid Leukemia and High Risk Myelodysplasia

A Clinical, Genomic and Proteomic Approach for the Characterization of Fanconi Anemia in Adolescent and Young Adult (AYA) Patients : A Single Center Study of 55 Patients from a National Bone Marrow Failure Referral Center

The Impact of Early Post-Transplant Cyclosporine Induced Acute Nephrotoxicity on Long Term Renal Function in 2-Year Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Retrospective Study

Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients

Development of Unique Molecular Signatures for Bone Marrow Failure Syndromes

Impact of Anti-Hepatitis B Core Following Allogeneic Bone Marrow Transplantation; Single Center Study of 489 Patients

Addition of ATG to Myeloablative Haplo Conditioning with Post-Transplantation Cyclophosphamide Might Decrease the Risk of Gvhd and TRM without Increasing the Risk of Relapse

BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation; Incidence and Risk Factors

Real-World Data Indicates That the Addition of Etoposide to Idarubicin and Cytarabine (3+7) Induction in Young Adults (<60 years) with AML Does Not Improve Survival or Remission Rates

Influence of Matched Sibling Donor's Availability and Stem Cell Transplantation on Treatment Outcome for Acute Lymphoblastic Leukemia; Study on 294 Patients

Young Adult Patients with Post -HCT Relapse of AML May Benefit from Aggressive Salvage and 2 nd Cellular Therapy

CD20 Expression Is Associated with Higher Risk of Early Relapse at 1 Year Following Chemotherapy Treatment for Adolescent and Adult Acute Lymphoblastic Leukemia Patients

Fertility Recovery Following Allogeneic Bone Marrow Transplantation in Aplastic Anemia; A Study of 157 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only